Study of Hydroxyurea to Treat Sickle Cell Disease
NCT02868138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2016-08-16
Summary
The aim of this single-center observational study was to evaluate quality of life, clinical effectiveness, and satisfaction in pediatric and young adult patients with sickle cell disease receiving hydroxyurea.
Conditions
Sponsors & Collaborators
-
Mersin University
lead OTHER
Principal Investigators
-
BAHAR TUNCTAN, Ph.D. · MERSIN UNIVERSITY FACULTY OF PHARMACY DEPARTMENT OF PHARMACOLOGY
Eligibility
- Min Age
- 7 Years
- Max Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Hydroxyurea in Young Children With Sickle Cell Anemia
NCT00519701 ·Status: COMPLETED ·Phase: NA
-
Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
NCT02149537 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
NCT00480974 ·Status: COMPLETED
-
Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
NCT02225132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
NCT07177300 ·Status: RECRUITING ·Phase: PHASE4
-
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
NCT00305175 ·Status: COMPLETED
-
Hydroxyurea in the Treatment of Sickle Cell Disease
NCT02709681 ·Status: COMPLETED
-
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
NCT03577691 ·Status: TERMINATED ·Phase: NA
-
Research Study Investigating How Well NDec Works in People With Sickle Cell Disease
NCT05405114 ·Status: COMPLETED ·Phase: PHASE2
-
Shared-Decision Making for Hydroxyurea
NCT03442114 ·Status: COMPLETED ·Phase: NA
-
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants
NCT06503458 ·Status: TERMINATED
-
Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia
NCT01506544 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Use Of Hydroxyurea in an African Region With Malaria
NCT01976416 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
NCT01895361 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App
NCT04675645 ·Status: COMPLETED ·Phase: NA
-
Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines
NCT03037021 ·Status: COMPLETED
-
Effects of HQK-1001 in Patients With Sickle Cell Disease
NCT01601340 ·Status: TERMINATED ·Phase: PHASE2
-
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
NCT04093986 ·Status: RECRUITING
-
Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa
NCT05681598 ·Status: COMPLETED ·Phase: NA
-
Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies
NCT03020615 ·Status: COMPLETED ·Phase: PHASE2
-
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
NCT00350844 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
NCT00270478 ·Status: COMPLETED ·Phase: PHASE1
-
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
NCT05285917 ·Status: RECRUITING ·Phase: PHASE3
-
Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas
NCT03128515 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence to Hydroxyurea in Children With Sickle Cell Anemia
NCT00672789 ·Status: COMPLETED ·Phase: NA